14 min. Read
10.02.20

Five investors talk digital therapeutics: Red flags, starting up, and COVID–19

At the virtual DTx East conference in September, five active investors with a focus on digital therapeutics discussed the market. Here are four of the topics they dug into:

  • What they look for in potential investment targets
  • Red flags when evaluating a digital therapeutic startup
  • What startups should look for in investors
  • How COVID--19 has just been a speedbump for some and created tailwinds for others
  • And more...

Here are the panelists and notes from their self-introductions:

Caleb Winder, Managing Director, MemorialCare Innovation Fund

We are focused on investing in healthcare companies across the US in early Series B or later.

Chihiro Hosoya Head of Venture Management & Business Development, Rx+ Business Accelerator Astellas Pharma

Astellas is a pharmaceutical company based in Japan but we operate globally. My scope includes both digital and devices, so we are super interested in

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Big buys Limbix. Better’s De Novo, pricing, GTM.
7.14.23
6 min. Read
MedRhythms InTandem now FDA-listed. Akili downloads.
7.07.23
6 min. Read
New Database: 150+ clinical trials for PDTs
6.30.23
6 min. Read
125 PDTs in pipelines. ICER expands into digital health
6.16.23
4 min. Read
Akili goes OTC. Pricing. New ISO DTx definition.
6.09.23
7 min. Read
Trials: Twill, Akili, Click. DiGA clawback leads to bankruptcy
6.02.23
6 min. Read
Pear bought Pear. New HCPCS attempts. Trials
5.26.23
8 min. Read
Pear sold for $6M. Woebot pauses PDTs. Swing-FDA
5.19.23
6 min. Read
Quest bought Pack Health for $123M cash. Trials
4.21.23
6 min. Read
New digital health CPT code hopefuls. Trials
4.14.23
5 min. Read
  • First
  • Previous
  • 1 of 18
  • Next
  • Last